Settling Vioxx Claims Wasn't An About-Face: Merck

Law360, New York (November 9, 2007, 12:00 AM EST) -- While Merck & Co., Inc. has long held that it would fight each lawsuit alleging its painkiller Vioxx caused serious health problems individually, it said the $4.85 billion settlement it agreed to Friday is not a change from – but a product of – its defense strategy.

The company said it decided to settle because the statute of limitations has closed in most jurisdictions and that it experienced some success with the cases that were taken to trial, which put it in an advantageous negotiation position....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.